Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02077140 · ClinicalTrials.gov registry record · Phase 2
A Study of MDT-10013 in the Treatment of Acute Postoperative Pain Following Bunionectomy
A Phase 2 study, sponsored by Medtronic Spinal and Biologics.
- Completed
- Registry status
- Phase 2
- Development phase
- 192
- Enrollment target
NCT02077140 is a Phase 2 study that has completed, run by Medtronic Spinal and Biologics. The registered enrollment target is 192 participants.
The verdict
NCT02077140, a Phase 2 study, has completed, sponsored by Medtronic Spinal and Biologics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 192 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy and safety of MDT-10013 in men and women 18 to 80 years of age who are undergoing bunionectomy. The primary objective is to determine the analgesic efficacy of MDT-10013 compared with standard of care in the treatment of acute postoperative pain after subjects undergo bunionectomy.
Interventions
- DRUG MDT-10013
- DRUG Standard of care for pain
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2014-02 |
| Est. Completion | 2016-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02077140
The ClinicalTrials.gov registry entry for NCT02077140 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Spinal and Biologics, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MDT-10013 is the first listed.
NCT02077140 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02077140 about?
NCT02077140 is a clinical study titled "A Study of MDT-10013 in the Treatment of Acute Postoperative Pain Following Bunionectomy". The purpose of this study is to evaluate the efficacy and safety of MDT-10013 in men and women 18 to 80 years of age who are undergoing bunionectomy. The primary objective is to determine the analgesic efficacy of MDT-10013 compared with standard of care in the treatment of acute postoperative pain ...
What is the current status of trial NCT02077140?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 192 participants. The study started on 2014-02. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02077140?
The interventions under investigation include: MDT-10013 (DRUG), Standard of care for pain (DRUG).
Who is sponsoring clinical trial NCT02077140?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.